Arca subcrenata Lischke is a marine traditional Chinese medicine. The study investigated the antitumor effects of P2, a polypeptide fraction from A. subcrenata, and its toxicity in vitro and in vivo. The results showed that P2 could inhibit the proliferation of seven tumor cell lines, especially in HeLa and HT-29 cell lines. The IC 50 values were 11.43 μg/mL for HeLa and 13.00 μg/mL for HT-29 treated by P2 for 48 h. P2 had little cytotoxicity on normal liver cells (L-02). The maximum tolerated dose (MTD) of P2 on KM mice was 1000 mg/kg by i.p. or i.v. The tumor growth inhibitory ratios of P2 were 26.4%, 41.4% and 46.4% for H-22, and 34.0%, 45.8% and 60.1% for S-180 tumor-bearing mice. The results demonstrated that P2 might be a potential antitumor agent with high efficiency in dose-dependent and time-dependent manners and low toxicity.
Kumar, N.S.S.; Nazeer, R.A.; Jaiganesh, R. Purification and identification of antioxidant peptides from the skin protein hydrolysate of two marine fishes, horse mackerel (Magalaspis cordyla) and croaker (Otolithes ruber). Amino Acids 2012, 42, 1641–1649, doi:10.1007/s00726-011-0858-6.
[3]
Wu, S.C.; Zhang, Z.X. Scavenging effects of extracts of Scapharca subcrenata on oxygen free radical. Mod. Food Sci. Technol. 2010, 26, 238–240.
[4]
Jiao, G.L.; Yu, G.L.; Wang, W.; Zhao, X.L.; Zhang, J.Z.; Ewart, S.H. Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities. J. Ocean Univ. China 2012, 11, 205–212, doi:10.1007/s11802-012-1906-x.
[5]
Galeano, E.; Thomas, O.P.; Robledo, S.; Munoz, D.; Martinez, A. Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida. Mar. Drugs 2011, 9, 1902–1913, doi:10.3390/md9101902.
[6]
Yoon, N.Y.; Kim, H.R.; Chung, H.Y.; Choi, J.S. Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch. Pharm. Res. 2008, 31, 1564–1571, doi:10.1007/s12272-001-2152-8.
[7]
Salma, Y.; Lafont, E.; Therville, N.; Carpentier, S.; Bonnafé, M.J.; Levade, T.; Génisson, Y.; Nathalie, A.A. The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem. Pharmacol. 2009, 78, 477–485, doi:10.1016/j.bcp.2009.05.002.
[8]
Fukahori, S.; Yano, H.; Akiba, J.; Ogasawara, S.; Momosaki, S.; Sanada, S.; Kuratomi, K.; Ishizaki, Y.; Moriya, F.; Yagi, M. Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro. Mol. Med. Rep. 2008, 1, 537–542.
[9]
Hyun, J.H.; Kim, S.C.; Kang, J.I.; Kim, M.K.; Boo, H.J.; Kwon, J.M.; Koh, Y.S.; Hyun, J.W.; Park, D.B.; Yoo, E.S. Apoptosis inducing activity of fucoidan in HCT-15 colon carcinoma cells. Biol. Pharm. Bull. 2009, 32, 1760–1764, doi:10.1248/bpb.32.1760.
[10]
Park, H.S.; Kim, G.Y.; Nam, T.J.; Kim, N.D.; Choi, Y.H. Anti-proliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells. J. Food Sci. 2011, 76, 77–83.
[11]
Wang, M.Y.; Nie, Y.X.; Peng, Y.; He, F.; Yang, J.Y.; Wu, C.F.; Li, X.B. Purification, characterization and antitumor activities of a new protein from Syngnathus acus, an officinal marine fish. Mar. Drugs 2012, 10, 35–50.
[12]
Kimura, M.; Wakimoto, T.; Egami, Y.; Tan, K.C.; Ise, Y.; Abe, I. Calyxamides A and B, cytotoxic cyclic peptides from the marine sponge Discodermia calyx. J. Nat. Prod. 2012, 75, 290–294, doi:10.1021/np2009187.
[13]
Ibrahim, S.R.M.; Min, C.C.; Teuscher, F.; Ebel, R.; Kakoschke, C.; Lin, W.; Wray, V.; Ebel, R.E.; Proksch, P. Callyaerins A–F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa. Bioorg. Med. Chem. 2010, 18, 4947–4956, doi:10.1016/j.bmc.2010.06.012.
[14]
Guo, X.S.; Li, Y. Marine Traditional Chinese Medicines; Sciences Press: Beijing, China, 2003; pp. 138–141.
[15]
Song, L.Y.; Li, T.F.; Yu, R.M.; Yan, C.Y.; Ren, S.F.; Zhao, Y. Antioxidant activities of hydrolysates of Arca subcrenata prepared with three proteases. Mar. Drugs 2008, 6, 607–619, doi:10.3390/md6040607.
[16]
Hu, X.Q.; Wu, H.M.; Lin, Z.M.; Fan, X.P. Preliminary study on physicochemical property of glycosaminoglycan from Arca subcrenata Lischke and its effects on immune organs of mice. Modern Food Sci. Technol. 2008, 24, 763–766.
[17]
Wang, L.; He, Y.M.; Yao, Q.S. Studies on immunomodulation of polysaccharide from Arca subcrenata Lischke. West China J. Pharm. Sci. 2009, 24, 340–342.
[18]
He, Y.M.; Liu, C.H.; Yao, Q.S. Isolation and structural characterization of a novel polysaccharide prepared from Arca subcrenata Lischke. J. Biosci. Bioeng. 2007, 104, 111–116, doi:10.1263/jbb.104.111.
[19]
Ren, S.F.; Song, L.Y.; Yu, R.M. Fingerprint analysis of anti-tumor active polypeptides from Arca subcrenata by HPLC. J. Chin. Med. Mater. 2008, 31, 1134–1138.
[20]
Song, L.Y.; Ren, S.F.; Yu, R.M.; Yan, C.Y.; Li, T.F.; Zhao, Y. Purification, characterization and in vitro antitumor activity of proteins from Arca subcrenata Lischke. Mar. Drugs 2008, 6, 418–430, doi:10.3390/md6030418.
[21]
Zhang, G.K.; Liu, H.Y.; Qi, F.S.; Wang, Y.H. Changes of ATP content during keeping-alive Scapharca subcrenata. Food Sci. Technol. 2011, 36, 120–123.
[22]
Kawabe, T. G2 checkpoint abrogators as anticancer drugs. Mol. Cancer Ther. 2004, 3, 513–519.
[23]
Tokarska-Schlattner, M.; Zaugg, M.; Zuppinger, C.; Wallimann, T.; Schlattner, U. New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics. J. Mol. Cell. Cardiol. 2006, 41, 389–405, doi:10.1016/j.yjmcc.2006.06.009.
[24]
Yeh, E.T.H.; Bickford, C.L. Cardiovascular complications of cancer therapy. J. Am. Coll. Cardiol. 2009, 53, 2231–2247, doi:10.1016/j.jacc.2009.02.050.
[25]
Wang, J.X.; Tong, X.; Li, P.B.; Cao, H.; Su, W.W. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. J. Ethnopharmacol. 2012, 139, 788–795, doi:10.1016/j.jep.2011.12.019.
[26]
Ghiringhelli, F.; Larmonier, N.; Schmitt, E.; Parcellier, A.; Cathelin, D.; Garrido, C.; Chauffert, B.; Solary, E.; Bonnotte, B.; Martin, F. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 2004, 34, 336–344, doi:10.1002/eji.200324181.
[27]
Mousinho, K.C.; de C. Oliveira, C.; de O. Ferreira, J.R.; Carvalho, A.A.; Magalh？es, H.I.F.; Bezerra, D.P.; Alves, A.P.N.N.; Costa-Lotufo, L.V.; Pessoa, C.; de Matos, M.P.V.; et al. Antitumor effect of laticifer proteins of Himatanthus drasticus (Mart.) Plumel—Apocynaceae. J. Ethnopharmacol. 2011, 137, 421–426, doi:10.1016/j.jep.2011.04.073.
[28]
Zhang, N.; Kong, X.L.; Yan, S.; Yuan, C.Z.; Yang, Q.F. Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci. 2010, 101, 2375–2383, doi:10.1111/j.1349-7006.2010.01680.x.
[29]
Tong, H.B.; Song, X.F.; Sun, X.; Sun, G.R.; Du, F.F. Immunomodulatory and antitumor activities of grape seed proanthocyanidins. J. Agric. Food Chem. 2011, 59, 11543–11547.
[30]
Huang, Y.J.; Song, L.Y.; Yu, R.M. Immunomodulatory activity of polypeptides extract from Arca subcrenata Lischke (PEAS) in vitro. Chin. J. Biochem. Pharm. 2011, 32, 273–277.
[31]
Wang, W.; Guo, Q.L.; You, Q.D.; Zhang, K.; Yang, Y.; Yu, J.; Liu, W.; Zhao, L.; Gu, H.Y.; Hu, Y. The anticancer activities of wogonin in murine Sarcoma S-180 both in vitro and in vivo. Biol. Pharm. Bull. 2006, 29, 1132–1137, doi:10.1248/bpb.29.1132.
[32]
Garrec, D.L.; Gori, S.; Luo, L.; Lessard, D.; Smith, D.C.; Yessine, M.A.; Ranger, M.; Leroux, J.C. Poly(N-vinylpyrrolidone)-block-poly(D, L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation. J. Control. Release 2004, 99, 83–101, doi:10.1016/j.jconrel.2004.06.018.
